Amy Barrie Appointed Chair of ESHRE Embryology SIG

FutureLife is proud to announce that Dr. Amy Barrie, Chief Scientific Officer at FutureLife, has been appointed Chair of the Embryology Special Interest Group (SIG) of the European Society of Human Reproduction and Embryology (ESHRE) for the 2026–2028 term.
 
ESHRE is one of the world's leading scientific organisations dedicated to reproductive medicine, bringing together clinicians, embryologists and researchers committed to advancing fertility care through research, education and collaboration. As Chair of the Embryology SIG, Dr. Barrie will lead one of ESHRE's most influential professional communities, helping shape its scientific and educational priorities over the next two years.
 
Working alongside the newly appointed coordination team, she will contribute to developing educational programmes, supporting the embryology community across Europe, strengthening scientific collaboration and driving initiatives that promote innovation and best practice in embryology.
 
This appointment reflects Dr. Barrie's longstanding commitment to scientific excellence and further reinforces FutureLife's position as a leading international group dedicated to advancing reproductive medicine through research, innovation and evidence-based clinical practice.
 
"I am honoured to have been appointed Chair of the Embryology Special Interest Group at ESHRE, one of the largest and most influential professional communities in reproductive medicine. In this role, I will help shape the scientific and educational agenda of the group, facilitate collaboration between leading embryologists across Europe, and contribute to advancing best practice in our field. This appointment provides FutureLife with greater visibility within the international scientific community and creates valuable opportunities for our scientists, ultimately supporting our commitment to delivering the highest standards of patient care. "

– Dr. Amy Barrie, Chief Scientific Officer, FutureLife
 
At FutureLife, scientific leadership extends beyond our clinics. By actively contributing to international organisations such as ESHRE, our experts help shape the future of reproductive medicine while ensuring that the latest scientific knowledge is translated into better patient outcomes.
 
We warmly congratulate Dr. Barrie and the entire ESHRE SIG Embryology Coordination Team for the 2026–2028 term and look forward to the impact their work will have on the future of embryology and fertility care.